Schedule 13D ownership disclosure

MIRA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 60458C104

Event date: 2023-08-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,760,270
Percent of class
23.8800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000897069-23-001176
Form type
SC 13D
Filer
Bay Shore Trust
CIK
CIK 1986593
Filed
Aug 14, 2023
Reporting period
Aug 02, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub